HEALTHCARE SERVICES GROUP (HCSG) Fundamental Analysis & Valuation
NASDAQ:HCSG • US4219061086
Current stock price
19.69 USD
+0.31 (+1.6%)
At close:
19.69 USD
0 (0%)
After Hours:
This HCSG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. HCSG Profitability Analysis
1.1 Basic Checks
- In the past year HCSG was profitable.
- HCSG had a positive operating cash flow in the past year.
- HCSG had positive earnings in each of the past 5 years.
- Of the past 5 years HCSG 4 years had a positive operating cash flow.
1.2 Ratios
- HCSG has a Return On Assets of 7.44%. This is amongst the best in the industry. HCSG outperforms 80.49% of its industry peers.
- HCSG has a Return On Equity of 11.58%. This is in the better half of the industry: HCSG outperforms 69.51% of its industry peers.
- With a decent Return On Invested Capital value of 6.29%, HCSG is doing good in the industry, outperforming 65.85% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for HCSG is below the industry average of 10.18%.
- The 3 year average ROIC (5.87%) for HCSG is below the current ROIC(6.29%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.44% | ||
| ROE | 11.58% | ||
| ROIC | 6.29% |
ROA(3y)5.74%
ROA(5y)5.59%
ROE(3y)9.29%
ROE(5y)9.23%
ROIC(3y)5.87%
ROIC(5y)6.53%
1.3 Margins
- HCSG has a better Profit Margin (3.21%) than 64.63% of its industry peers.
- HCSG's Profit Margin has declined in the last couple of years.
- With a Operating Margin value of 2.64%, HCSG perfoms like the industry average, outperforming 47.56% of the companies in the same industry.
- In the last couple of years the Operating Margin of HCSG has declined.
- HCSG has a worse Gross Margin (13.03%) than 85.37% of its industry peers.
- HCSG's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.64% | ||
| PM (TTM) | 3.21% | ||
| GM | 13.03% |
OM growth 3Y-5.85%
OM growth 5Y-16.88%
PM growth 3Y16.23%
PM growth 5Y-10.53%
GM growth 3Y4.36%
GM growth 5Y-3.06%
2. HCSG Health Analysis
2.1 Basic Checks
- HCSG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- HCSG has less shares outstanding than it did 1 year ago.
- The number of shares outstanding for HCSG has been reduced compared to 5 years ago.
- There is no outstanding debt for HCSG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- HCSG has an Altman-Z score of 6.50. This indicates that HCSG is financially healthy and has little risk of bankruptcy at the moment.
- HCSG's Altman-Z score of 6.50 is amongst the best of the industry. HCSG outperforms 82.93% of its industry peers.
- There is no outstanding debt for HCSG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 6.5 |
ROIC/WACC0.7
WACC8.97%
2.3 Liquidity
- A Current Ratio of 3.38 indicates that HCSG has no problem at all paying its short term obligations.
- With an excellent Current ratio value of 3.38, HCSG belongs to the best of the industry, outperforming 85.37% of the companies in the same industry.
- HCSG has a Quick Ratio of 3.28. This indicates that HCSG is financially healthy and has no problem in meeting its short term obligations.
- With an excellent Quick ratio value of 3.28, HCSG belongs to the best of the industry, outperforming 87.80% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.38 | ||
| Quick Ratio | 3.28 |
3. HCSG Growth Analysis
3.1 Past
- HCSG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 172.22%, which is quite impressive.
- Measured over the past 5 years, HCSG shows a small growth in Earnings Per Share. The EPS has been growing by 2.18% on average per year.
- The Revenue has been growing slightly by 7.08% in the past year.
- The Revenue has been growing slightly by 0.86% on average over the past years.
EPS 1Y (TTM)172.22%
EPS 3Y46.87%
EPS 5Y2.18%
EPS Q2Q%175%
Revenue 1Y (TTM)7.08%
Revenue growth 3Y2.82%
Revenue growth 5Y0.86%
Sales Q2Q%6.59%
3.2 Future
- HCSG is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.64% yearly.
- HCSG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.12% yearly.
EPS Next Y-34.26%
EPS Next 2Y-13.33%
EPS Next 3Y-2.64%
EPS Next 5YN/A
Revenue Next Year5.28%
Revenue Next 2Y5.25%
Revenue Next 3Y5.12%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. HCSG Valuation Analysis
4.1 Price/Earnings Ratio
- HCSG is valuated correctly with a Price/Earnings ratio of 13.39.
- HCSG's Price/Earnings ratio is rather cheap when compared to the industry. HCSG is cheaper than 81.71% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 25.61, HCSG is valued a bit cheaper.
- HCSG is valuated rather expensively with a Price/Forward Earnings ratio of 20.37.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of HCSG indicates a somewhat cheap valuation: HCSG is cheaper than 68.29% of the companies listed in the same industry.
- HCSG's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.79.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.39 | ||
| Fwd PE | 20.37 |
4.2 Price Multiples
- HCSG's Enterprise Value to EBITDA ratio is in line with the industry average.
- HCSG's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HCSG is cheaper than 84.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.94 | ||
| EV/EBITDA | 17.62 |
4.3 Compensation for Growth
- A cheap valuation may be justified as HCSG's earnings are expected to decrease with -2.64% in the coming years.
PEG (NY)N/A
PEG (5Y)6.16
EPS Next 2Y-13.33%
EPS Next 3Y-2.64%
5. HCSG Dividend Analysis
5.1 Amount
- HCSG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
HCSG Fundamentals: All Metrics, Ratios and Statistics
19.69
+0.31 (+1.6%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)02-11 2026-02-11/bmo
Earnings (Next)04-21 2026-04-21/bmo
Inst Owners105.78%
Inst Owner Change-3.46%
Ins Owners1.29%
Ins Owner Change2.45%
Market Cap1.38B
Revenue(TTM)1.84B
Net Income(TTM)59.06M
Analysts80
Price Target24.99 (26.92%)
Short Float %2.61%
Short Ratio2.4
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)138.38%
Min EPS beat(2)87.55%
Max EPS beat(2)189.22%
EPS beat(4)4
Avg EPS beat(4)75.83%
Min EPS beat(4)1.3%
Max EPS beat(4)189.22%
EPS beat(8)5
Avg EPS beat(8)22.26%
EPS beat(12)7
Avg EPS beat(12)4.06%
EPS beat(16)9
Avg EPS beat(16)9.47%
Revenue beat(2)0
Avg Revenue beat(2)-1.59%
Min Revenue beat(2)-2.07%
Max Revenue beat(2)-1.11%
Revenue beat(4)0
Avg Revenue beat(4)-1.17%
Min Revenue beat(4)-2.07%
Max Revenue beat(4)-0.28%
Revenue beat(8)0
Avg Revenue beat(8)-1.51%
Revenue beat(12)0
Avg Revenue beat(12)-2.02%
Revenue beat(16)1
Avg Revenue beat(16)-1.66%
PT rev (1m)13.95%
PT rev (3m)13.95%
EPS NQ rev (1m)-5.78%
EPS NQ rev (3m)-11.67%
EPS NY rev (1m)-1.1%
EPS NY rev (3m)-5.06%
Revenue NQ rev (1m)-2.6%
Revenue NQ rev (3m)-2.72%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.39 | ||
| Fwd PE | 20.37 | ||
| P/S | 0.75 | ||
| P/FCF | 9.94 | ||
| P/OCF | 9.54 | ||
| P/B | 2.71 | ||
| P/tB | 3.27 | ||
| EV/EBITDA | 17.62 |
EPS(TTM)1.47
EY7.47%
EPS(NY)0.97
Fwd EY4.91%
FCF(TTM)1.98
FCFY10.06%
OCF(TTM)2.06
OCFY10.48%
SpS26.14
BVpS7.26
TBVpS6.03
PEG (NY)N/A
PEG (5Y)6.16
Graham Number15.5
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.44% | ||
| ROE | 11.58% | ||
| ROCE | 7.78% | ||
| ROIC | 6.29% | ||
| ROICexc | 8.6% | ||
| ROICexgc | 10.62% | ||
| OM | 2.64% | ||
| PM (TTM) | 3.21% | ||
| GM | 13.03% | ||
| FCFM | 7.57% |
ROA(3y)5.74%
ROA(5y)5.59%
ROE(3y)9.29%
ROE(5y)9.23%
ROIC(3y)5.87%
ROIC(5y)6.53%
ROICexc(3y)7.65%
ROICexc(5y)8.71%
ROICexgc(3y)9.39%
ROICexgc(5y)10.93%
ROCE(3y)7.36%
ROCE(5y)8.23%
ROICexgc growth 3Y-4.73%
ROICexgc growth 5Y-20.16%
ROICexc growth 3Y-4.1%
ROICexc growth 5Y-20.1%
OM growth 3Y-5.85%
OM growth 5Y-16.88%
PM growth 3Y16.23%
PM growth 5Y-10.53%
GM growth 3Y4.36%
GM growth 5Y-3.06%
F-Score8
Asset Turnover2.31
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 34.68% | ||
| Cap/Sales | 0.32% | ||
| Interest Coverage | 28.89 | ||
| Cash Conversion | 221.95% | ||
| Profit Quality | 235.61% | ||
| Current Ratio | 3.38 | ||
| Quick Ratio | 3.28 | ||
| Altman-Z | 6.5 |
F-Score8
WACC8.97%
ROIC/WACC0.7
Cap/Depr(3y)38.6%
Cap/Depr(5y)37.71%
Cap/Sales(3y)0.34%
Cap/Sales(5y)0.33%
Profit Quality(3y)132.28%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)172.22%
EPS 3Y46.87%
EPS 5Y2.18%
EPS Q2Q%175%
EPS Next Y-34.26%
EPS Next 2Y-13.33%
EPS Next 3Y-2.64%
EPS Next 5YN/A
Revenue 1Y (TTM)7.08%
Revenue growth 3Y2.82%
Revenue growth 5Y0.86%
Sales Q2Q%6.59%
Revenue Next Year5.28%
Revenue Next 2Y5.25%
Revenue Next 3Y5.12%
Revenue Next 5YN/A
EBIT growth 1Y20.06%
EBIT growth 3Y-3.19%
EBIT growth 5Y-16.16%
EBIT Next Year837.83%
EBIT Next 3Y132.92%
EBIT Next 5YN/A
FCF growth 1Y468.75%
FCF growth 3YN/A
FCF growth 5Y-8.15%
OCF growth 1Y370.65%
OCF growth 3YN/A
OCF growth 5Y-7.77%
HEALTHCARE SERVICES GROUP / HCSG Fundamental Analysis FAQ
What is the ChartMill fundamental rating of HEALTHCARE SERVICES GROUP (HCSG) stock?
ChartMill assigns a fundamental rating of 5 / 10 to HCSG.
Can you provide the valuation status for HEALTHCARE SERVICES GROUP?
ChartMill assigns a valuation rating of 4 / 10 to HEALTHCARE SERVICES GROUP (HCSG). This can be considered as Fairly Valued.
Can you provide the profitability details for HEALTHCARE SERVICES GROUP?
HEALTHCARE SERVICES GROUP (HCSG) has a profitability rating of 5 / 10.
Can you provide the financial health for HCSG stock?
The financial health rating of HEALTHCARE SERVICES GROUP (HCSG) is 9 / 10.
What is the earnings growth outlook for HEALTHCARE SERVICES GROUP?
The Earnings per Share (EPS) of HEALTHCARE SERVICES GROUP (HCSG) is expected to decline by -34.26% in the next year.